Concepedia

Publication | Open Access

SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

DOIFull Paper Access

106

Citations

27

References

2015

Year

Kate Lynn J. Bill, Jeannine Garnett, Isabelle Meaux, XiaoYen Ma, Chad J. Creighton, Svetlana Bolshakov, Cédric Barrière, Laurent Debüssche, Alexander J. Lazar, Bethany C. Prudner,
Clinical Cancer Research

Abstract

SAR405838 is currently in early-phase clinical trials for a number of malignancies, including sarcoma, and our in vitro and in vivo results support its use as a potential therapeutic strategy for the treatment of DDLPS.

References

YearCitations

Page 1